Nadene Zack
Celcuity Inc
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nadene Zack as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:57 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06190899 · Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate CancerCelcuity Inc · recruiting · mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, Urogenital Diseases, Male · study director
- Ph3NCT05501886 · Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)Celcuity Inc · active not recruiting · Breast Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:57 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- 159 citationsRCR 5.5
- Assessment of the test-retest reliability of laboratory polysomnography.Sleep Breath · 2009106 citationsRCR 3.8
- Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis: A Randomized Controlled Trial.Obstet Gynecol · 20228 citationsRCR 0.9
- 6 citationsRCR 1.1
- Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study.Menopause · 20234 citationsRCR 0.6
- Safety and acceptability of intravaginal rings releasing estradiol and progesterone.Climacteric · 20234 citationsRCR 0.7
- 4 citationsRCR 0.9
- A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis.J Antimicrob Chemother · 20222 citationsRCR 0.2
- Acceptability of Single-dose Clindamycin Gel for Bacterial Vaginosis: A Randomized Controlled Trial.Clin Ther · 20232 citationsRCR 0.4
- 2 citationsRCR 0.5